Armed with positive phase 3 results, Venatorx has said it will file for approval its cefepime-taniborbactam combination with the FDA later this year for complicated urinary tract infections (cUTI ...

The FDA has given the green light to Exblifep, based on long-established beta-lactam antibiotic cefepime and a new extended-spectrum beta-lactamase inhibitor (BLI) called enmetazobactam ...

But if the previous question was “monitoring parameters for Cefepime,” then it becomes clear that the correct interpretation of the question is “monitoring parameters for vancomycin” The ...

The leading Complicated Urinary Tract Infection Companies such as Spero Therapeutics, Iterum Therapeutics, Venatorx Pharmaceuticals Inc., Nabriva Therapeutics, Allecra Therapeutics, Wockhardt, MerLion ...